Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EV/Net Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Net Sales(x) 2.182.112.201.171.59

What is the latest EV/Net Sales ratio of AUROBINDO PHARMA ?

The latest EV/Net Sales ratio of AUROBINDO PHARMA is 2.18 based on Mar2026 Consolidated results.
Year EV/Net Sales
Mar20262.18
Mar20252.11
Mar20242.20
Mar20231.17
Mar20221.59

How is EV/Net Sales of AUROBINDO PHARMA Trending?

Years EV/Net Sales % Change
Mar2026 2.18
3.32
Mar2025 2.11
-4.09
Mar2024 2.2
88.03
Mar2023 1.17
-26.42
Mar2022 1.59 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EV/Net Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹98,468.2 Cr -0.3% 5.5% 53.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.3%

5.5%

53.8%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses